Vinmec Research Institute of Stem Cell and Gene Technology
30
3
3
25
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 30 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 25 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (30)
Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment
Role: lead
CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
Role: lead
Autologous BMMNCs Combined With Educational Intervention for ASD
Role: lead
Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis
Role: lead
Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50
Role: lead
Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy From Brain Hypoxia
Role: lead
CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
Role: lead
Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty
Role: lead
Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment
Role: lead
Stem Cell Infusion in the Treatment of Patients with Neurological Sequelae After Ischemic Stroke
Role: lead
Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae
Role: lead
Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis
Role: lead
Convalescent Plasma for COVID-19 Patients
Role: lead
Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia
Role: lead
Convalescent Plasma for COVID-19 Patients (CPCP)
Role: lead
Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency
Role: lead
Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female
Role: lead
Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia
Role: lead
Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia
Role: lead
Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency
Role: lead